We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.
DIGITAL LANDIA, LLC IN COOPERATION WITH PETVIVO HOLDINGS, INC. UNVEILS REVOLUTIONARY AUTONOMOUS PET AI ECOSYSTEM TRANSFORMING PET CARE WITH SELF-LEARNING MULTI-AGENT AI TECHNOLOGY
MIAMI, FL, May 13, 2025 (GLOBE NEWSWIRE) -- Digital Landia, LLC, in cooperation with PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW) and its wholly owned subsidiary PetVivo Animal Health, Inc. (collectively referred to herein as "PetVivo"), today announces the upcoming launch of AgenticPet.ai, the world's first autonomous pet care AI ecosystem that leverages cutting-edge multi-agent technology to revolutionize how we understand and care for our animal companions. Set for public release on May 23, 2025, this groundbreaking platform creates specialized AI agents that continuously learn and evolve to provide unprecedented insights into pet health and wellness.
"AgenticPet.ai represents a paradigm shift in pet care technology," said Karim Quazzani, CEO of Digital Landia. "By creating an ecosystem of self-learning AI agents that collaborate as an interconnected swarm, we're enabling pet owners to understand their companions in ways previously unimaginable. Furthermore, we're building more than just another pet app; AgenticPet.ai is creating a new category of intelligent pet care that will continuously evolve to meet the needs of veterinarians, pets and their owners."
Breakthrough Self-Creating AI Technology
Unlike conventional pet care applications, AgenticPet.ai's framework autonomously spawns specialized AI agents that "graduate" through rigorous digital certification exams. These super agents achieve expert-level mastery in veterinary diagnostics, behavior analysis, nutrition, and more. The system continuously adapts by creating new agents based on incoming pet data, ensuring relevance across evolving health, behavioral, and environmental variables.
Comprehensive Pet Care Through Specialized Agents
The platform features an impressive array of specialized AI agents working in concert:
Veterinary Diagnostics Agent: Assesses overall pet health using imaging, lab results, and sensor data;
Behavioral Analysis Agent: Interprets pet behavior using video and audio feeds to identify stress, anxiety, or other issues;
Nutritional Advisor Agent: Delivers personalized dietary plans by integrating scientific research with individual pet needs;
Emotional Wellness Agent: Evaluates a pet's emotional state through advanced audio analysis and facial expression recognition; and
IoT Data Integration Agent: Acts as a hub for real-time sensor data, preparing for next-generation integration with devices capturing vital signs and biometric measurements.
Real-World Applications That Transform Pet Ownership
AgenticPet.ai brings remarkable capabilities to everyday pet care scenarios:
The Pet Translator: Decodes subtle cues like tail movements, blinking patterns, and vocal intonations to communicate messages such as "Bella is feeling slightly anxious today”;
Early Disease Detection: Identifies minute changes in gait, posture, or behavior that might indicate developing health conditions before they become serious; and
Comprehensive Wellness Reports: Aggregates data across multiple dimensions to provide holistic health insights and proactive care recommendations.
Innovative Business Model
AgenticPet.ai will launch with a tiered pricing structure designed to make this revolutionary technology accessible to pet owners everywhere:
Freemium Tier: Entry-level access with limited tokens to experience the platform;
Premium Subscription ($9.95/month): Multiple pet profiles with on-demand access to individual AI agents; and
Elite Package ($24.95/month): Comprehensive access to the full AI swarm for in-depth pet wellbeing reports.
The platform also features innovative B2B integration through proprietary MCP/Gibberlink protocols, allowing veterinary practices, pet care providers, and pet product companies to communicate directly with pet owners' AI agents.
Growth Trajectory
With a proven track record of onboarding over 270,000 users in previous ventures, Digital Landia projects 100,000 freemium users within six months of launch. Conservative estimates suggest a 10% conversion to paid subscriptions, generating nearly $2 million in annual recurring revenue.
“AgenticPet.ai represents a major advance in how we understand our pets,” said John Lai, CEO of PetVivo Holdings, Inc. “By aligning clinically proven therapies, like Spryng® with OsteoCushion® Technology and PrecisePRP, with this very powerful AI technology, we position PetVivo at the intersection of AI innovation and veterinary care. We anticipate Pet AI will provide an incredibly valuable resource to veterinarians and pet owners alike, as well as, create unparalleled visibility for PetVivo brands, including SPRYNG and PrecisePRP.”
About Digital Landia
Digital Landia specializes in developing cutting-edge AI solutions that bridge the gap between advanced technology and everyday needs. The company is dedicated to creating accessible, practical applications of artificial intelligence that enhance quality of life.
PetVivo Holdings Inc. (OTCQB: PETV; OTCPINK: PETVW) is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The Company's strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics.
PetVivo has a robust pipeline of products for the treatment of animals and people. A portfolio of twenty-one patents protects the Company's biomaterials, products, production processes and methods of use. The Company’s lead products SPRYNG™ with OsteoCushion™ technology, a veterinarian-administered, intra-articular injection for the management of lameness and other joint related afflictions, including osteoarthritis, in cats, dogs and horses, and PrecisePRP, a first-in-class, off-the-shelf, platelet-rich plasma (PRP) product designed for use by veterinarians, are currently available for commercial sale.
Contact Information: John Lai, CEO PetVivo Holdings, Inc. Email: info1@petvivo.com (952) 405-6216
Forward-Looking Statements:
The foregoing material may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended. Forward-looking statements include all statements that do not relate solely to historical or current facts, including without limitation the Company’s proposed development and commercial timelines, and can be identified by the use of words such as “may,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,” “continue” or the negative versions of those words or other comparable words. Forward-looking statements are not guarantees of future actions or performance. These forward-looking statements are based on information currently available to the Company and its current plans or expectations and are subject to a number of uncertainties and risks that could significantly affect current plans. Risks concerning the Company’s business are described in detail in the Company’s Annual Report on Form 10-K for the year ended March 31, 2024 and other periodic and current reports filed with the Securities and Exchange Commission. The Company is under no obligation to, and expressly disclaims any such obligation to, update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
